Viewing Study NCT04652102


Ignite Creation Date: 2025-12-25 @ 3:47 AM
Ignite Modification Date: 2026-06-06 @ 5:37 PM
Study NCT ID: NCT04652102
Status: COMPLETED
Last Update Posted: 2024-04-29
First Post: 2020-12-01
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Phase 2b/3, Randomized, Observer-Blinded, Placebo-Controlled, Multicenter Clinical Study Evaluating the Efficacy and Safety of Investigational SARS-CoV-2 mRNA Vaccine CVnCoV in Adults 18 Years of Age and Older
Sponsor: CureVac
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Covid19 View
None SARS-CoV-2 View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Vaccine View